Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
Clinical trial NCT02478398 · COMPLETED
Trial details
- NCT number
- NCT02478398
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-20
- Primary completion
- 2018-11-09
- Enrollment
- 1025
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.